252 related articles for article (PubMed ID: 31144725)
1. Predictors of Return to Normal Neurological Function After Surgery for Moderate and Severe Degenerative Cervical Myelopathy: An Analysis of A Global AOSpine Cohort of Patients.
De la Garza Ramos R; Nouri A; Nakhla J; Echt M; Gelfand Y; Patel SK; Nasser R; Cheng JS; Yassari R; Fehlings MG
Neurosurgery; 2019 Nov; 85(5):E917-E923. PubMed ID: 31144725
[TBL] [Abstract][Full Text] [Related]
2. Postoperative Resolution of Magnetic Resonance Imaging Signal Intensity Changes and the Associated Impact on Outcomes in Degenerative Cervical Myelopathy: Analysis of a Global Cohort of Patients.
Kato S; Nouri A; Reihani-Kermani H; Oshima Y; Cheng J; Fehlings MG
Spine (Phila Pa 1976); 2018 Jun; 43(12):824-831. PubMed ID: 28953706
[TBL] [Abstract][Full Text] [Related]
3. Association of myelopathy scores with cervical sagittal balance and normalized spinal cord volume: analysis of 56 preoperative cases from the AOSpine North America Myelopathy study.
Smith JS; Lafage V; Ryan DJ; Shaffrey CI; Schwab FJ; Patel AA; Brodke DS; Arnold PM; Riew KD; Traynelis VC; Radcliff K; Vaccaro AR; Fehlings MG; Ames CP
Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S161-70. PubMed ID: 23963001
[TBL] [Abstract][Full Text] [Related]
4. Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy.
Tetreault L; Wilson JR; Kotter MR; Nouri A; Côté P; Kopjar B; Arnold PM; Fehlings MG
Neurosurg Focus; 2016 Jun; 40(6):E14. PubMed ID: 27246484
[TBL] [Abstract][Full Text] [Related]
5. Surgery for Degenerative Cervical Myelopathy: What Really Counts?
Gembruch O; Jabbarli R; Rashidi A; Chihi M; Hetze S; Barthel L; Toplak A; El Hindy N; Sure U; Dammann P; Özkan N
Spine (Phila Pa 1976); 2021 Mar; 46(5):294-299. PubMed ID: 33065693
[TBL] [Abstract][Full Text] [Related]
6. Clinical and magnetic resonance imaging predictors of the surgical outcomes of patients with cervical spondylotic myelopathy.
Li XY; Lu SB; Sun XY; Kong C; Guo MC; Sun SY; Ding JZ; Yang YM
Clin Neurol Neurosurg; 2018 Nov; 174():137-143. PubMed ID: 30241007
[TBL] [Abstract][Full Text] [Related]
7. A clinical prediction model to determine outcomes in patients with cervical spondylotic myelopathy undergoing surgical treatment: data from the prospective, multi-center AOSpine North America study.
Tetreault LA; Kopjar B; Vaccaro A; Yoon ST; Arnold PM; Massicotte EM; Fehlings MG
J Bone Joint Surg Am; 2013 Sep; 95(18):1659-66. PubMed ID: 24048553
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Surgery for Mild Degenerative Cervical Myelopathy: Results of the AOSpine North America and International Prospective Multicenter Studies.
Badhiwala JH; Witiw CD; Nassiri F; Akbar MA; Mansouri A; Wilson JR; Fehlings MG
Neurosurgery; 2019 Apr; 84(4):890-897. PubMed ID: 29684181
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Anterior and Posterior Surgery for Degenerative Cervical Myelopathy: An MRI-Based Propensity-Score-Matched Analysis Using Data from the Prospective Multicenter AOSpine CSM North America and International Studies.
Kato S; Nouri A; Wu D; Nori S; Tetreault L; Fehlings MG
J Bone Joint Surg Am; 2017 Jun; 99(12):1013-1021. PubMed ID: 28632590
[TBL] [Abstract][Full Text] [Related]
10. A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy: Analysis of an International Prospective Multicenter Data Set of 757 Subjects.
Tetreault L; Kopjar B; Côté P; Arnold P; Fehlings MG
J Bone Joint Surg Am; 2015 Dec; 97(24):2038-46. PubMed ID: 26677238
[TBL] [Abstract][Full Text] [Related]
11. Does Magnetic Resonance Imaging Improve the Predictive Performance of a Validated Clinical Prediction Rule Developed to Evaluate Surgical Outcome in Patients With Degenerative Cervical Myelopathy?
Nouri A; Tetreault L; Côté P; Zamorano JJ; Dalzell K; Fehlings MG
Spine (Phila Pa 1976); 2015 Jul; 40(14):1092-100. PubMed ID: 25893357
[TBL] [Abstract][Full Text] [Related]
12. Trajectory of Improvement in Myelopathic Symptoms From 3 to 12 Months Following Surgery for Degenerative Cervical Myelopathy.
Khan I; Archer KR; Wanner JP; Bydon M; Pennings JS; Sivaganesan A; Knightly JJ; Foley KT; Bisson EF; Shaffrey C; McGirt MJ; Asher AL; Devin CJ;
Neurosurgery; 2020 Jun; 86(6):763-768. PubMed ID: 31435676
[TBL] [Abstract][Full Text] [Related]
13. Is Preoperative Duration of Symptoms a Significant Predictor of Functional Outcomes in Patients Undergoing Surgery for the Treatment of Degenerative Cervical Myelopathy?
Tetreault L; Wilson JR; Kotter MRN; Côté P; Nouri A; Kopjar B; Arnold PM; Fehlings MG
Neurosurgery; 2019 Nov; 85(5):642-647. PubMed ID: 30445506
[TBL] [Abstract][Full Text] [Related]
14. A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients.
Tetreault LA; Côté P; Kopjar B; Arnold P; Fehlings MG;
Spine J; 2015 Mar; 15(3):388-97. PubMed ID: 25549860
[TBL] [Abstract][Full Text] [Related]
15. Machine learning algorithms for prediction of health-related quality-of-life after surgery for mild degenerative cervical myelopathy.
Khan O; Badhiwala JH; Witiw CD; Wilson JR; Fehlings MG
Spine J; 2021 Oct; 21(10):1659-1669. PubMed ID: 32045708
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Improvements in Myelopathy and Sagittal Realignment in Cervical Deformity Surgery Outcomes.
Passias PG; Horn SR; Bortz CA; Ramachandran S; Burton DC; Protopsaltis T; Lafage R; Lafage V; Diebo BG; Poorman GW; Segreto FA; Smith JS; Ames C; Shaffrey CI; Kim HJ; Neuman B; Daniels AH; Soroceanu A; Klineberg E;
Spine (Phila Pa 1976); 2018 Aug; 43(16):1117-1124. PubMed ID: 29462071
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Worse Functional Status After Surgery for Degenerative Cervical Myelopathy: A Machine Learning Approach.
Khan O; Badhiwala JH; Akbar MA; Fehlings MG
Neurosurgery; 2021 Feb; 88(3):584-591. PubMed ID: 33289519
[TBL] [Abstract][Full Text] [Related]
18. The discrepancy between functional outcome and self-reported health status after surgery for degenerative cervical myelopathy.
Tetreault LA; Zhu MP; Howard RM; Sorefan-Mangou F; Patel AA; Schroeder GD; Massicotte EM; Bhadiwala JH; Fehlings MG; Wilson JR
Spine J; 2019 Nov; 19(11):1809-1815. PubMed ID: 31278991
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies.
Bohm PE; Fehlings MG; Kopjar B; Tetreault LA; Vaccaro AR; Anderson KK; Arnold PM
Spine J; 2017 Feb; 17(2):211-217. PubMed ID: 27592193
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Fehlings MG; Badhiwala JH; Ahn H; Farhadi HF; Shaffrey CI; Nassr A; Mummaneni P; Arnold PM; Jacobs WB; Riew KD; Kelly M; Brodke DS; Vaccaro AR; Hilibrand AS; Wilson J; Harrop JS; Yoon ST; Kim KD; Fourney DR; Santaguida C; Massicotte EM; Kopjar B
Lancet Neurol; 2021 Feb; 20(2):98-106. PubMed ID: 33357512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
